Suivre
Joshua Matthew Rhett
Joshua Matthew Rhett
Scientific Director, The Lockwood Group
Adresse e-mail validée de thelockwoodgrp.com
Titre
Citée par
Citée par
Année
Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1
JM Rhett, J Jourdan, RG Gourdie
Molecular biology of the cell 22 (9), 1516-1528, 2011
3302011
Novel therapies for scar reduction and regenerative healing of skin wounds
JM Rhett, GS Ghatnekar, JA Palatinus, M O’Quinn, MJ Yost, RG Gourdie
Trends in biotechnology 26 (4), 173-180, 2008
3292008
Populations of the European freshwater pulmonate Physa acuta are not reproductively isolated from American Physa heterostropha or Physa integra
RT Dillon Jr, AR Wethington, JM Rhett, TP Smith
Invertebrate Biology 121 (3), 226-234, 2002
2292002
Cx43 Associates with Nav1.5 in the Cardiomyocyte Perinexus
JM Rhett, EL Ongstad, J Jourdan, RG Gourdie
The Journal of membrane biology 245, 411-422, 2012
1382012
The perinexus: a new feature of Cx43 gap junction organization
JM Rhett, RG Gourdie
Heart rhythm 9 (4), 619-623, 2012
1182012
The connexin43 carboxyl terminus and cardiac gap junction organization
JA Palatinus, JM Rhett, RG Gourdie
Biochimica et Biophysica Acta (BBA)-Biomembranes 1818 (8), 1831-1843, 2012
1042012
Therapeutic targeting of RAS: New hope for drugging the “undruggable”
I Khan, JM Rhett, JP O'Bryan
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867 (2), 118570, 2020
942020
The perinexus: sign-post on the path to a new model of cardiac conduction?
JM Rhett, R Veeraraghavan, S Poelzing, RG Gourdie
Trends in cardiovascular medicine 23 (6), 222-228, 2013
742013
The unstoppable connexin43 carboxyl‐terminus: new roles in gap junction organization and wound healing
RG Gourdie, GS Ghatnekar, M O'QUINN, MJ Rhett, RJ Barker, C Zhu, ...
Annals of the New York Academy of Sciences 1080 (1), 49-62, 2006
692006
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical …
YES Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS
BMC Cancer 15 (1), 296, 2015
68*2015
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies
G Virella, SR Thorpe, NL Alderson, MB Derrick, C Chassereau, JM Rhett, ...
Journal of lipid research 45 (10), 1859-1867, 2004
682004
Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response
BW Calder, JM Rhett, H Bainbridge, SA Fann, RG Gourdie, MJ Yost
Tissue Engineering Part A 21 (11-12), 1752-1762, 2015
662015
Connexin 43, breast cancer tumor suppressor: Missed connections?
CL Grek, JM Rhett, JS Bruce, GS Ghatnekar, ES Yeh
Cancer letters 374 (1), 117-126, 2016
602016
Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium
JA Palatinus, JM Rhett, RG Gourdie
Journal of molecular and cellular cardiology 48 (3), 550-557, 2010
562010
Enhanced PKCε mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury
JA Palatinus, JM Rhett, RG Gourdie
Channels 5 (3), 236-240, 2011
532011
Cardiac to cancer: connecting connexins to clinical opportunity
CL Grek, JM Rhett, GS Ghatnekar
FEBS letters 588 (8), 1349-1364, 2014
502014
Freshwater gastropoda
RT Dillon, AR Wethington, JM Rhett, TP Smith
The mollusks: a guide to their study, collection, and preservation. The …, 2006
382006
HUNK phosphorylates EGFR to regulate breast cancer metastasis
CB Williams, K Phelps-Polirer, IP Dingle, CJ Williams, MJ Rhett, ST Eblen, ...
Oncogene 39 (5), 1112-1124, 2020
362020
Mechanism of action of the anti-inflammatory connexin43 mimetic peptide JM2
JM Rhett, BW Calder, SA Fann, H Bainbridge, RG Gourdie, MJ Yost
American Journal of Physiology-Cell Physiology 313 (3), C314-C326, 2017
302017
Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues
JM Rhett, SA Fann, MJ Yost
Tissue Engineering Part B: Reviews 20 (5), 392-402, 2014
302014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20